We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MetLife (MET) to Report Q2 Earnings: What's in the Offing?
Read MoreHide Full Article
MetLife, Inc. (MET - Free Report) is set to release its second-quarter 2019 earnings on Jul 31, 2019.
The Zacks Consensus Estimate for its earnings per share is pegged at $1.32 (up 1.54% year over year) on revenues of $16.5 billion (down 22.3%).
Factors Affecting Q2 Results
Within the U.S. business segment, Group Benefits is expected to report strong underwriting results for both life and Non-Medical Health coverage. This business is also likely to report increase in sales of voluntary products. The company’s brand name, product sets, customer base and distribution reach should drive sales of voluntary products.
We expect low single-digit growth in property and casualty revenues and the underwriting gains should be offset to some extent from catastrophe losses incurred during the to-be-reported quarter.
Favorable underwriting and investment margins, solid volume growth, as well as lower taxes will likely aid operating earnings in Retirement and Income Solutions segment.
In the company’s International business, we expect higher contributions from Asia led by rise in Accident & Health (A&H) and foreign currency products in Japan, and greater A&H sales in India and Japan. The unit cost initiatives undertaken by the company should lead to a decline in adjusted expense ratio.
Share repurchases made by MetLife in the to-be-reported quarter will likely add to its bottom line.
Earnings Surprise History
The company boasts an attractive earnings surprise history. It beat estimates in each of the last four quarters with an average positive surprise of 9.8%. This is depicted in the chart below:
Our proven model does not conclusively show that MetLife is likely to beat on earnings estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. But that is not the case here as you will see below.
Earnings ESP: MetLife has an Earning ESP of -0.54%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: MetLife carries a Zacks Rank #4 (Sell). We caution against Sell-rated stocks (Zacks Rank #4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks That Warrant a Look
Here are some companies that you may consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:
American Financial Group, Inc. (AFG - Free Report) has an Earnings ESP of +0.66% and a Zacks Rank #3.
Alleghany Corp. has an Earnings ESP of +1.74% and a Zacks Rank #3.
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
Image: Bigstock
MetLife (MET) to Report Q2 Earnings: What's in the Offing?
MetLife, Inc. (MET - Free Report) is set to release its second-quarter 2019 earnings on Jul 31, 2019.
The Zacks Consensus Estimate for its earnings per share is pegged at $1.32 (up 1.54% year over year) on revenues of $16.5 billion (down 22.3%).
Factors Affecting Q2 Results
Within the U.S. business segment, Group Benefits is expected to report strong underwriting results for both life and Non-Medical Health coverage. This business is also likely to report increase in sales of voluntary products. The company’s brand name, product sets, customer base and distribution reach should drive sales of voluntary products.
We expect low single-digit growth in property and casualty revenues and the underwriting gains should be offset to some extent from catastrophe losses incurred during the to-be-reported quarter.
Favorable underwriting and investment margins, solid volume growth, as well as lower taxes will likely aid operating earnings in Retirement and Income Solutions segment.
In the company’s International business, we expect higher contributions from Asia led by rise in Accident & Health (A&H) and foreign currency products in Japan, and greater A&H sales in India and Japan.
The unit cost initiatives undertaken by the company should lead to a decline in adjusted expense ratio.
Share repurchases made by MetLife in the to-be-reported quarter will likely add to its bottom line.
Earnings Surprise History
The company boasts an attractive earnings surprise history. It beat estimates in each of the last four quarters with an average positive surprise of 9.8%. This is depicted in the chart below:
MetLife, Inc. Price and EPS Surprise
MetLife, Inc. price-eps-surprise | MetLife, Inc. Quote
Here is what the quantitative model predicts:
Our proven model does not conclusively show that MetLife is likely to beat on earnings estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. But that is not the case here as you will see below.
Earnings ESP: MetLife has an Earning ESP of -0.54%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: MetLife carries a Zacks Rank #4 (Sell). We caution against Sell-rated stocks (Zacks Rank #4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks That Warrant a Look
Here are some companies that you may consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:
Lincoln National Corp. (LNC - Free Report) has an Earnings ESP of +0.71% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
American Financial Group, Inc. (AFG - Free Report) has an Earnings ESP of +0.66% and a Zacks Rank #3.
Alleghany Corp. has an Earnings ESP of +1.74% and a Zacks Rank #3.
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
See the 7 breakthrough stocks now>>